Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,860 | -2,158 | 3,027 | 4,192 | 2,772 |
| Depreciation Amortization | 3,024 | 1,470 | 1,242 | 557 | 368 |
| Accounts receivable | -7,964 | -1,038 | -12,367 | -11,647 | -6,054 |
| Accounts payable and accrued liabilities | 3,677 | 2,782 | -256 | 486 | -149 |
| Other Working Capital | -20,189 | -5,201 | -8,646 | -10,653 | -7,241 |
| Other Operating Activity | 13,392 | 2,665 | 21,630 | 16,247 | 8,325 |
| Operating Cash Flow | $-10,920 | $-1,480 | $4,630 | $-818 | $-1,979 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,108 | -780 | -4,364 | -3,068 | -1,760 |
| Net Acquisitions | N/A | N/A | -17,000 | N/A | N/A |
| Purchase Of Investment | -1,587 | N/A | 371 | 371 | 371 |
| Investing Cash Flow | $-3,695 | $-780 | $-20,993 | $-2,697 | $-1,389 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | 0 | -2,772 | -2,772 | -2,772 |
| Common Stock Issued | 810 | 364 | 216,331 | 216,314 | 317 |
| Common Stock Repurchased | 765 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -67 | 0 | 0 | 0 | -1,081 |
| Financing Cash Flow | $1,508 | $364 | $213,559 | $213,542 | $-3,536 |
| Exchange Rate Effect | -1,617 | -216 | 1,303 | 625 | 631 |
| Beginning Cash Position | 364,618 | 364,618 | 166,119 | 166,119 | 166,119 |
| End Cash Position | 349,894 | 362,506 | 364,618 | 376,771 | 159,846 |
| Net Cash Flow | $-14,724 | $-2,112 | $198,499 | $210,652 | $-6,273 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,920 | -1,480 | 4,630 | -818 | -1,979 |
| Capital Expenditure | -2,108 | -780 | -4,364 | -3,068 | -1,760 |
| Free Cash Flow | -13,028 | -2,260 | 266 | -3,886 | -3,739 |